LEADER 00999nam0 2200337   450 
001 990000996660203316
035   $a0099666
035   $aUSA010099666
035   $a(ALEPH)000099666USA01
035   $a0099666
100   $a19980923g19869999|||||ita|01 ba
101   $aeng
102   $aUS
105   $a|||| |||||
200 1 $aIndustrial organic chemicals in perspective$fHarold A. Wittcoff, Bryan G. Reuben
210   $aNew York$cJ. Wiley & sons$dc1986
215   $aXXIV, 531 p$d24 cm
606 0 $aSostanze organiche nell'industria
676   $a661.8
700  1$aWITTCOFF,$bHarold A.$090782
701  1$aREUBEN,$bBryan G.$022865
801  0$aIT$bsalbc$gISBD
912   $a990000996660203316
951   $a661.8 WIT$b9899 ING$c661.8
959   $aBK
969   $aTEC
979   $aPATTY$b90$c20020226$lUSA01$h1520
979   $c20020403$lUSA01$h1741
979   $aPATRY$b90$c20040406$lUSA01$h1709
996   $aIndustrial organic chemicals in perspective$9975065
997   $aUNISA

LEADER 02558nam  22005534a 450 
001 9910455886703321
005 20200520144314.0
010   $a1-280-36806-3
010   $a9786610368068
010   $a0-471-64757-8
035   $a(CKB)111087027135856
035   $a(EBL)176858
035   $a(OCoLC)54993076
035   $a(SSID)ssj0000112452
035   $a(PQKBManifestationID)11830359
035   $a(PQKBTitleCode)TC0000112452
035   $a(PQKBWorkID)10087236
035   $a(PQKB)11632212
035   $a(MiAaPQ)EBC176858
035   $a(Au-PeEL)EBL176858
035   $a(CaPaEBR)ebr10114052
035   $a(CaONFJC)MIL36806
035   $a(EXLCZ)99111087027135856
100   $a20030815d2004      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aBiotech industry$b[electronic resource] $ea global, economic, and financing overview /$fBryan Bergeron
210   $aHoboken, N.J. $cJohn Wiley & Sons$dc2004
215   $a1 online resource (384 p.)
300   $aDescription based upon print version of record.
311   $a0-471-46561-5 
320   $aIncludes bibliographical references (p. 337-345) and index.
327   $aBiotech Industry; About the Authors; Contents; Preface; Acknowledgments; CHAPTER 1 Overview; CHAPTER 2 Pharmaceuticals; CHAPTER 3 Medicine and Agriculture; CHAPTER 4 Computing, Biomaterials, and the Military; CHAPTER 5 Infrastructure; CHAPTER 6 Financing; CHAPTER 7 Regional Analysis; CHAPTER 8 Outlook; Appendix; Glossary; Sources and Further Reading; Index
330   $a""The biotech industry is a complex, rapidly evolving, and critical industry. The industry holds great commercial and societal promise, but it is also filled with hype, confusion, and risks. Bergeron and Chan do a remarkable job of providing a sweeping insightful, and probing assessment of the current state and likely evolution of this global industry. This book is essential reading for the executive who desires a thorough understanding of this business and its potential.""--John P. Glasser, Vice President and Chief Information Offers, Partners Healthcare System, Inc.""Bergeron and Chan ha
606   $aBiotechnology industries
608   $aElectronic books.
615  0$aBiotechnology industries.
676   $a338.4/76606
700   $aBergeron$b Bryan P$0883230
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910455886703321
996   $aBiotech industry$91972908
997   $aUNINA